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Plasmodium vivax: the last malaria parasite? - The 
renewed momentum for global malaria eradication has 
generated the need for further study of P. vivax (Alonso 
et al. 2011). In fact, the burden of P. vivax seems to be in-
creasing from 70-80 million to 130-435 million clinical 
cases per year and threatens 2.6 billion people (Mendis 
et al. 2001, Hay et al. 2004, Guerra et al. 2010). Frequent 
relapses of infection with this species and the emergence 
of chloroquine resistance are two major factors likely re-
sponsible for this increasing burden of P. vivax malaria 
(Kochar et al. 2005, Baird 2007, Price et al. 2007). No-
tably, in South and Southeast Asia, P. vivax infections 
represent more than 50% of malaria cases, whereas in 
Central and South America infections by P. vivax can 
reach up to 70-90%. Thus, P. vivax is most prevalent ma-
laria outside Sub-Saharan Africa.
Notably, the life cycle and biology of P. vivax differ 
from those of Plasmodium falciparum (Table). The fol-
lowing differences are worth highlighting: (i) P. vivax 
sporozoites can enter hepatocytes and remain dormant 
as hypnozoites, which are responsible for clinical relaps-
es (Krotoski 1985), (ii) P. vivax preferentially, if not ex-
clusively, invades reticulocytes (Kitchen 1938), and this 
is arguably the reason why parasitemias are low in natu-
ral vivax infection, (iii) gametocytes appear in the blood 
before clinical symptoms are manifest, which compli-
cates and compromises clinical treatment and control of 
the disease (Boyd & Kitchen 1937), and (iv) mosquito 
vectors from areas where P. vivax is more prevalent are 
outdoor-biting and anthropophilic, which makes control 
measures, such as impregnated bed nets, of limited val-
ue. Experts therefore agree that due to this unique biol-
ogy, the present tools used to control P. falciparum will 
not suffice for P. vivax, which reinforces the importance 
of understanding the biology, epidemiology and pathol-
ogy of P. vivax (Mueller et al. 2009). 
Pathology of P. vivax - Pathogenesis in falciparum 
malaria is multi-factorial and involves numerous host 
and parasite factors. However, central to this pathogen-
esis are the phenomena of antigenic variation, rosetting 
and cytoadherence (Miller et al. 2002). Antigenic varia-
tion refers to the capacity of parasites to clonally express 
variant proteins at the surface of infected red blood cells 
(IRBCs) and this function to evade the host immune re-
sponse and allow for the establishment of chronic infec-
tion (Brown & Brown 1965). Rosetting is the formation 
of rosettes resulting from the adhesion of erythrocytes 
infected with mature forms of the parasite to uninfected 
erythrocytes and this process has been shown to increase 
the microvascular obstruction of blood flow (David et al. 
1988). Cytoadherence refers to the capacity of IRBC to 
adhere to host cells. This process has been described for 
the endothelium and for the placenta and it causes the 
disappearance of mature trophozoites and schizonts from 
the peripheral blood (Bignami & Bastianelli 1889, Miller 
et al. 1994). Remarkably, the original search for genes re-
sponsible for these phenomena identified a single subtelo-
meric multigene variant family named the var gene fam-
ily (Baruch et al. 1995, Smith et al. 1995, Su et al. 1995). 
P. falciparum var genes encode proteins collectively 
known as PfEMP1 that contain ligand domains for dif-
ferent endothelial receptors, such as CD36, intercellular 
adhesion molecule-1 (ICAM-1) and chondroitin sulphate 
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It is generally accepted that Plasmodium vivax, the most widely distributed human malaria parasite, causes mild 
disease and that this species does not sequester in the deep capillaries of internal organs. Recent evidence, however, 
has demonstrated that there is severe disease, sometimes resulting in death, exclusively associated with P. vivax and 
that P. vivax-infected reticulocytes are able to cytoadhere in vitro to different endothelial cells and placental cryo-
sections. Here, we review the scarce and preliminary data on cytoadherence in P. vivax, reinforcing the importance 
of this phenomenon in this species and highlighting the avenues that it opens for our understanding of the pathology 
of this neglected human malaria parasite.
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A (CSA). Furthermore, var gene expression is associated 
with various clinical syndromes of severe falciparum dis-
ease (Pasternak & Dzikowski 2009). In addition to var 
genes, the full genome sequence of P. falciparum has 
revealed additional subtelomeric multigene families that 
are likely involved in the pathology of malaria (Gardner 
et al. 2002). These data therefore indicate that expression 
of P. falciparum multigene families, which are clustered 
in subtelomeric regions, is associated with the pathology 
of falciparum malaria and the phenomena of antigenic 
variation, rosetting and cytoadherence.
Studies from P. vivax patients in Sri Lanka have shown 
that P. vivax undergoes antigenic variation and that the 
mature forms have the capacity for rosetting (Udagama 
et al. 1987, Udomsanpetch et al. 1995). Thus, using im-
mune sera from primary-infected or multiply infected P. 
vivax patients, immunofluorescence assays from differ-
ent isolates have revealed that only patients with multiple 
infections were able to recognise several different iso-
lates (Udagama et al. 1987). Moreover, rosetting experi-
ments using blood and wild isolates revealed that close 
to 70% of the isolates showed rosetting (Udomsanpetch 
et al. 1995). However, approaches similar to those used 
for studies of cytoadhesion in P. falciparum (Hasler et al. 
1993) failed to observe the cytoadhesion of P. vivax-in-
fected reticulocytes to human umbilical vein endothelial 
cells, C32 melanoma cells, platelets or to purified CD36. 
Notably, sequence analysis of a P. vivax isolate revealed 
the presence of a subtelomeric multigene variant super-
family termed vir (P. vivax variant genes), which is likely 
involved in antigenic variation in this species (del Portillo 
et al. 2001). Further analyses have indicated that vir genes 
could have additional functions and it was hypothesised 
that they mediate adhesion to facilitate the establishment 
of chronic infection (del Portillo et al. 2004). The complete 
genome sequence of the Sal I strain revealed the pres-
ence of additional subtelomeric gene families (Carlton et 
al. 2008), which further indicated that P. vivax, like P. 
falciparum, has clustered multigene families at its chro-
mosome ends. However, the relationship between these 
gene families and pathology has been mostly overlooked, 
as vivax malaria had been predominantly accepted to be 
clinically benign and not to cytoadhere.
In the last 10 years, the severe complications observed 
in P. falciparum infection, which include renal failure, 
jaundice, acute respiratory distress syndrome, cerebral 
malaria, seizures, anemia, hyperparasitemia, thrombo-
cytopenia, pulmonary edema, splenic rupture and death, 
have also been reported worldwide for P. vivax (Kochar 
et al. 2005, 2009, Baird 2007, Price et al. 2007, Alexandre 
et al. 2010). However, diagnosis was made in most cases 
using Giemsa staining, which cast reasonable doubts as 
to the potential for undetectable infection with P. falci-
parum. The use of nested polymerase chain reactions 
(PCRs) to exclude the possibility of mixed infection, 
however, has confirmed sole infection with P. vivax in 
some of these reports. In addition, the clinical exclusion 
of other syndromes, such as those caused by respiratory 
TABLE
Main biological differences between Plasmodium vivax and Plasmodium falciparum
P. vivax P. falciparum
Seventy-300 million yearly clinical cases 
(Mendis et al. 2001, Hay et al. 2004). 
Three hundred-500 million yearly clinical cases  
(Guerra et al. 2007). 
Usually non-lethal and non-severe; yet this situation has radically 
changed recently (Kochar et al. 2009).
Lethal and severe, responsible for close to one million 
deaths each year mostly in children under five years old.
Sporozoites can remain within hepatocytes in dormant stages known  
as hypnozoites (Krotoski 1985). 
Sporozoites within hepatocytes undergo immediate 
schizogony with no dormant stages.
Hypnozoites cause clinical relapses. There are no clinical relapses.
Invades preferentially, if not exclusively, reticulocytes (Kitchen 1938). Invades all red blood cells.
Requires mainly (Chitnis & Sharma 2008), but not exclusively 
(Mercereau-Puijalon & Menard 2010), the Duffy Blood Group  
as the receptor for entrance into reticulocytes.
Has multiple entrance pathways and receptors  
(Cowman & Crabb 2006). 
Surface membrane of infected reticulocytes suffers invaginations 
called caveola vesicles.
Surface membrane of infected red blood cells suffers 
protrusions called knobs.
Continuous in vitro culture not available. Continuous in vitro culture available since 1976  
(Trager & Jensen 1976). 
Gametocytes appear in peripheral blood before clinical symptoms 
(Boyd & Kitchen 1937).
Gametocytes appear in peripheral blood after clinical 
symptoms.
Mosquito vectors are mostly outdoor bitting. Mosquito vectors are mostly indoor bitting.
Chloroquine resistance first reported in 1989. Chloroquine resistance first reported in late 1950s.
Complete genome sequence first reported in 2008  
(Carlton et al. 2008).
Complete genome sequence first reported in 2002  
(Gardner et al. 2002). 
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pathogens, human immunodeficiency virus, histoplasma, 
coccidians and paracoccidians, as well as the adoption of 
World Health Organization criteria used for severe falci-
parum disease, are now being adopted for the reports of 
new cases of severe vivax disease. In Brazil, for instance, 
a recent study from the city of Manaus, Amazonas, 
showed an increased number of hospital admissions for 
P. vivax-infected patients (Santos-Ciminera et al. 2007) 
with increased clinical severity, which were mostly re-
lated to jaundice and severe anaemia after P. falciparum 
or other possible causes of disease were excluded (Ale- 
xandre et al. 2010). Similar to what has been observed in 
Brazil, an increasing number of cases with complications 
have been reported worldwide (Anstey et al. 2009). These 
data illustrate and confirm that there is indeed an aug-
mentation of the number of severe cases exclusively as-
sociated with P. vivax infection across different endemic 
regions of the world. Nevertheless, whether this severity 
is directly associated with changes in parasite biology, 
increasing resistance to antimalarial drugs or with the 
presence of comorbidities is still a matter of debate.
Although it has long been axiomatic that P. vivax is 
less virulent than P. falciparum due to its lack of cytoad-
herence, the existence of subtelomeric variant families 
in the genome of P. vivax and the recent confirmed re-
ports of severe vivax disease have led us to question the 
validity of this view. Moreover, in spite of studies that 
have documented the presence of all stages of P. vivax 
in the peripheral blood of infected patients, previous 
studies revealed that the presence of mature forms were 
disproportionably lower than young stages, indicating 
a segmentation of these mature forms somewhere else 
than in peripheral blood (Field et al. 1963).
Cytoadherence of P. vivax-infected reticulocytes - In 
an attempt to elucidate whether cytoadhesion is a P. fal-
ciparum-restricted phenomenon, a recent collaborative 
study by our groups (Carvalho et al. 2010) demonstrated 
that P. vivax-IRBC (Pv-IRBCs) obtained from Brazilian 
patients with non-severe disease were able to cytoadhere 
under static or flow conditions to brain, lung (Fig. 1), pla-
cental and endothelial receptors, which have previously 
been implicated in the binding of P. falciparum (Beeson 
& Brown 2002). Under static conditions, the number per 
mm2 of adherent Pv-IRBC was 10-15-fold lower than 
that of P. falciparum-IRBC (Pf-IRBC). However, the 
percentage of parasites able to bind endothelial recep-
tors under flow conditions did not differ significantly. 
These results differ from those previously reported in 
Sri Lanka (Udomsanpetch et al. 1995). One explanation 
for this discrepancy is that our cytoadhesion assays used 
percoll-enriched mature forms of the parasite at pH 6.8, 
whereas this other studies has used forms obtained di-
rectly from the blood at pH 7.4.
To identify potential endothelial receptors involved 
in P. vivax adherence, CHO cells expressing different 
endothelial receptors were used for adhesion assays. We 
found greater adhesion to ICAM-1-transfected cells in 
comparison to CD36-transfected or untransfected cells. 
However, we cannot rule out the role of additional host 
receptors in Pv-IRBC. Moreover, adhesion of parasites to 
endothelial cells was significantly inhibited by the addi-
tion of soluble CSA, although treatment of the same cells 
with chondroitinase-ABC (CaseABC) did not affect adhe-
sion (Carvalho et al. 2010). These results indicated that 
the CSA backbone was not directly involved in parasite 
adhesion. As CSA is highly negatively charged due to the 
presence of sulphate groups, the inhibition of cytoadhe-
sion may be sustained by a charge interaction. Indeed, it 
has been shown that the binding of several P. falciparum 
VAR2CSA domains to CSA at various salt concentrations 
is not different from their binding to non-placental do-
mains, which demonstrates that binding to CSA is highly 
dependent on ionic strength (Resende et al. 2009).
We hypothesised that Vir proteins, due to their vari-
ant nature, sub-cellular localisation and genome organi-
sation, could mediate P. vivax cytoadherance. By using 
two different antibodies raised against two different Vir 
proteins, the specific inhibition of the IRBC-endothelial 
cell interaction was demonstrated (Carvalho et al. 2010). 
To perform functional binding assays in the absence of 
a continuous in vitro culture system for P. vivax, 3D7 P. 
falciparum transgenic lines expressing different Vir pro-
teins, motifs, protein domains and secondary structures 
have been generated (M Bernabeu & C Fernandez-Be- 
cerra, unpublished observations). Notably, one of these 
transgenic lines that expressed Vir proteins on the surface 
of the IRBC mediated cytoadherence to ICAM-1, VCAM 
and E-selectin. Moreover, two polyclonal, mono-specific 
anti-Vir antibodies significantly inhibited this adhesion. 
Together, these data further support our findings and indi-
cate that P. vivax-infected reticulocytes can cytoadhere to 
a variety of endothelial receptors and that this adherence 
is at least partially mediated specifically by Vir proteins.
Cytoadherence and severe vivax disease - The recent 
findings that infection with P. vivax can lead to severe 
complications in endemic areas worldwide (Kochar et al. 
2005, Lomar et al. 2005, Tjitra et al. 2008) have led the 
scientific community to search for the mechanisms of 
pathogenesis related to this infection, which have been 
neglected thus far. One of the major arguments against 
the severity of P. vivax infection was based on the lack 
of cytoadherence and the formation of knobs by this 
parasite. However, robust evidence points to the exis-
tence of severe falciparum disease without the presence 
of the aforementioned mechanisms, which therefore 
suggests that these are not the sine qua non for sever-
ity (Maegraith 1948). As reviewed above, cytoadhesion 
was demonstrated for P. vivax using an in vitro approach 
(Carvalho et al. 2010) and unpublished data on adhesion 
to the placenta (FTM Costa & MVG Lacerda, unpub-
lished observations) (Fig. 2), lungs and spleen (MVG 
Lacerda & H del Portillo, unpublished observations) 
have recently been obtained. When IRBCs are found in-
side of blood vessels in human tissues, there is no way 
to confirm that cytoadhesion has taken place, and this 
possibility should also be taken into account for previous 
studies of P. falciparum-infected tissues. 
There is not much information available on autopsies 
related to vivax infection, which could lend support to 
cytoadherence during severe vivax disease. As reviewed 
elsewhere (Anstey et al. 2009), however, early XX cen-
tury autopsies for which P. vivax diagnosis was based on 
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thick blood smears reported the presence of intracapil-
lary masses of swollen, infected erythrocytes and pig-
ment (Billings & Post 1915). In addition, these autopsies 
reported the frequent presence of mature malaria para-
sites within a red blood cell taking up the entire lumen 
and being in immediate contact with endothelial cells in 
some vessels in the brain, as well as an unusually large 
number of infected red cells and young plasmodia and a 
large amount of pigment in intestinal submucosal vessels 
(Bruetsch 1932). In these cases, however, comorbidities 
and mixed infection with P. falciparum were not prop-
erly discarded. More recently, one autopsy from India, 
which had confirmed P. vivax monoinfection by PCR, 
found congestion of alveolar capillaries by monocytic 
infiltrates and diffuse damage to alveolar membranes 
consistent with acute respiratory distress syndrome. 
Parasites were observed in lung tissue as well as in other 
organs without lesions (Valecha et al. 2009). Despite 
the fact that this is evidence from a single case, this re-
sembles the findings of cytoadhesion in P. falciparum 
pulmonary disease (Corbett et al. 1989). From measure-
ments of gas transfer and lung volume in non-severe 
vivax patients, the progressive alveolar-capillary dys-
function following treatment was found to be consistent 
with the greater inflammatory response induced by this 
parasite (Anstey et al. 2007). As a major complication of 
severe vivax disease, the pathogenesis of respiratory dis-
tress requires further investigation into the cytoadhesion 
that takes place, as suggested by studies of in vitro adhe-
sion and endothelial activation of lung microvasculature. 
In fact, the host inflammatory response, the endothelial 
Weibel-Palade body release, and the plasma concentra-
tions of angiopoietin-2, ICAM-1, E-selectin, interleukin 
(IL)-6 and IL-10 are greater in patients with vivax com-
pared to P. falciparum malaria (Yeo et al. 2010). As the 
addition of lipopolysaccharide was found to increase the 
adhesion of IRBCs to human lung endothelial cells in 
vitro (Carvalho et al. 2010), it is possible that secondary 
bacterial infections may release endotoxins that could 
contribute to the enhanced endothelial activation and cy-
toadhesion. Thus, coinfections and pathogenesis during 
vivax infection require further investigation.
The role of platelets in cytoadhesion is well-docu-
mented for severe falciparum malaria. Here, platelets 
participate in strengthening the adhesion of IRBCs to 
CD36 (known as glycoprotein IV in platelets), which most 
likely explains their accumulation in brain microves- 
sels (Grau et al. 2003, Wassmer et al. 2004). Platelets can 
also participate in tumor necrosis factor (TNF)-induced 
microvascular pathology (Lou et al. 1997, Wassmer et al. 
2006) and platelet-derived microparticles seem to play 
an important role in endothelial activation (Combes et al. 
2006). Despite strong evidence that vivax disease triggers 
greater thrombocytopenia than does falciparum disease 
(Kochar et al. 2010), there are no data available on the 
ability of these particles to enhance vivax cytoadhesion.
As reviewed elsewhere (Clark & Alleva 2009), se-
questration in the bone marrow has been shown to cause 
the dyserythropoiesis observed in P. falciparum malaria 
(Wickramasinghe et al. 1987). Dyserythropoiesis was 
demonstrated in the bone marrow during P. vivax infec-
tion, where cytoadhesion was not thought to play a role 
(Wickramasinghe et al. 1989). As a result, the idea of cy-
toadhesion as the cause of severe anaemia was abandoned 
and the presence of increased TNF levels was shown to in-
duce dyserythropoiesis in both species (Clark & Chaudhri 
1988). The presence of P. vivax parasites in the bone mar-
row prompts the need for clarification on its implications 
for disease pathogenesis (Lacerda et al. 2008).
Perspectives and concluding remarks - Demonstra-
tion of the cytoadherence of P. vivax opens new inves-
tigational lines of research. First, proteomic analysis of 
adhesion proteins and Vir proteins on the surface of in-
fected reticulocytes should further the identification of 
new parasite ligands. In addition, microscopic analyses 
from autopsies where coinfections have been ruled out 
will reinforce the presence of parasite cytoadherence. 
The role of cytoadherence to the spleen, lungs and pla-
centa in the establishment of chronic infection will fur-
ther reveal the molecular basis of pathology in P. vivax 
malaria and the demonstration of cytoadhesion in other 
tissues, such as the kidneys and bone marrow will con-
firm existing observations of severe disease and the as-
sociation between cytoadhesion and severe disease syn-
Fig. 1: adhesion of Plasmodium vivax-infected erythrocytes matur-
ing forms to endothelial cells. A: Giemsa staining of P. vivax mature 
forms obtained after Percoll enrichment. Representative photomicro-
graphs of P. vivax-infected red blood cells adhesion to human lung; B: 
Saimiri brain; C: endothelial cells.
Fig. 2: presence of Plasmodium vivax-infected red blood cells at-
tached to the synciotrophoblast of a placenta from a patient diag-
nosed with P. vivax in the 36th week of pregnancy (optical micros-
copy, 1,000X, Thomas’ stain).
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dromes. Furthermore, technological breakthroughs in 
noninvasive imaging will demonstrate whether P. vivax-
infected reticulocytes adhere to different organs in vivo 
and whether this adhesion is associated with severe vivax 
malaria. Ultimately, understanding the factors that deter-
mine P. vivax-associated morbidity and severe disease 
will contribute to the control, elimination and eradication 
of malaria worldwide (Bassat & Alonso 2011).
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